Quercetin is a flavonol present at high levels in onions, apples, tea and red wine. Although quercetin has been epidemiologically associated with bioactive protective effects, this compound has also been shown to be mutagenic and toxic in short-term in vitro test systems. This study evaluated quercetin for toxicity in the MCF-7 cell line in the presence or absence of benzo [a]pyrene (B[a]P), a known DNA-reactive carcinogen. In the clonogenic assay, 2.5 × 10 2 cells were seeded into 25 cm 2 flasks in the presence or absence of graded concentrations of quercetin and/or B[a]P. In the cytokinesis block micronucleus (CBMN) assay, 3 ml aliquot (≈2 × 10 4 cells) was seeded into 30 mm petri dishes containing 20 mm coverslips; cells were treated with graded concentrations of quercetin and/or B[a]P for 24 h (Yared et al., 2002). All test agents were evaluated at micromolar (µM) concentrations. Results were obtained from at least three independent experiments and analyzed for significant mean differences using a Student's t-test. Differences with P ≤ 0.05 were considered statistically significant between groups. For quantitative real-time transcriptase polymerase chain reaction (RT-PCR), total RNA extraction was performed using the Qiagen RNeasy ® kit in combination with Qiagen RNase-free DNase kit. Quercetin induced dose-related increases in cytotoxicity in the clonogenic assay and micronucleus formation in CBMN assay. However in the presence of B[a]P, quercetin exerted significant protective effects demonstrated by enhanced % survival in the clonogenic assay and reductions in micronucleus formation in the CBMN assay. RT-PCR revealed down-regulated levels of expression of P21 WAF1/CIP1 and CYP1A1 in cells incubated in the presence of both quercetin and B[a]P compared to levels of induction noted in cells exposed to B[a]P alone. This study provides evidence of quercetin-induced genotoxicity/cytotoxicity in vitro. However, it also points to quercetin-associated protective effects against a prototypical carcinogen (i.e., B[a]P) that might be important in an epidemiological setting.
INTRODUCTION
Flavanoids are a known ubiquitous and diverse group of phenolics derived from shikimate and acetate precursors. The flavanoids are a family of structurally related pigments which are largely confined to vascular plants (Lea & Leegood, 1999) . Flavanoids occur generally as glycosylated and sulfated derivatives with sub classes as flavonols, flavanones and isoflavones (Middleton et al., 2000) . Recognised for their bioactive potential and as natural components in the human diet, flavanoids are increasingly being ingested by the general population as a result of the burgeoning interest in alternative medicine (Galati & O' Brien, 2004) . Although more than 6000 flavanoids have been identified and found to occur in fruits, vegetables, nuts, seeds, tea, red wine and lots more, a much smaller number is regarded as important from a dietary point of view (Erlund, 2004) .
The flavanol quercetin (3,3',4',5,7-pentahydroxy flavone) is naturally occuring and widely distributed in dietary plants with the estimated dietary consumption in humans as 16-1000mg/day (Tieppo et al., 2007) . Quercetin is one of the predominant flavanoids present in the diet with richest sources being onions, apples, tea and red wine (Moon et al., 2009) . Quercetin is present in plants in various glycosidic forms. Quercetin exists as quercetin 4'-glucoside and quercetin-3, 4' glucoside in onions, quercetin galactosides in apples and quercetin arabinosidse in berries (Erlund, 2004) .
Absorption and Metabolism
The absorption, metabolism, distribution and accumulation of compounds or substances within an organism accounts for the ability of such compounds or substances to exert beneficial or deleterious effects in an organism (Klassen, 2008) . Absorption and metabolism of most ingested compounds and food substances begin in the gastrointestinal (GI) tract. For flavonoids, the important sites of metabolism are the GI lumen, cells of the intestinal wall and the liver (Erlund 2004) .
Using a cell model of human intestinal absorption (Caco-2 cell line), the conjugation of quercetin has been demonstrated (Ikeno et al., 1999) . Similarly, quercetin-4'-glucoside is transported within Caco-2 cell line though effluxed from the cells by the secretory protein multidrug resistance -associated protein 2 (MRP-2) . Although attempts have been made to analyze quercetin glycosides in plasma, using mass spectrometry or high performance liquid chromatography (HPLC) has been difficult due to similarities in retention times for flavonoid glucoronides and glycosides as well as their non-specific ultraviolet spectra (Manach et al., 1998; Nielsen and Dragsted, 1998; Wittig et al., 2001; Arts et al., 2002) . Despite these, Sesink et al., (2001) identified quercetin glucoronides as major metabolites in human plasma.
The catechol-like stucture of quercetin makes it predictably prone to O-methylation by soluble catechol-O-methyltransferase (COMT) (Walle, 2004) , a reaction that has been well studied for quercetin in vivo in hamsters and in in vitro experiments . This reaction tends to be more efficient for quercetin than the O-methylation of catechol estrogens and catecholamines. The product isorhamnetin or 3'-O-methylquercetin has been found in human studies . In vitro studies have indicated a range of biological activities for quercetin including antioxidative (Hayek et al., 1997; Chopra et al., 2000) , anti-inflammatory (Ferry et al., 1996) anti-carcinogenic (Verma et al., 1988; Deschner et al., 1991; Pereira et al., 1996) , vasodilating (Perez-vizcaino et al., 2002) and antiaggregatory (Pignatelli et al., 
2000) effects.Mechanism of Action
Quercetin has been observed to exert beneficial properties through mechanisms such as:
Reduction in ischemia-reperfusion injury through interference with inducible nitricoxide synthase activity (Shokes, 1998) .
Decreasing oxidative injury by inhibiting xanthine oxidase activity (Chang et al., 1993; Iio et al., 1986; Shoskes, 1998) .
The inhibition of malignant cell growth by arresting them in the late G 1 phase of the cycle (Yoshida et al., 1992) .
Reduction of free radical development by chelating iron (Fe) (Ferrali et al., 1997) .
Direct inhibition of lipid peroxidation (Sorata et al., 1984) .
The inhibition of cofactor recruitment at the chromatin of proinflammatory genes (Ruiz et al., 2007) .
Inhibition of pro inflammatory cytokine gene expression through the modulation of NF-kβ system (Nair et al., 2006) .
The induction of apoptosis via direct activation of the mitochondria caspase cascade (Granado-serrano et al., 2006) .
Suppressing activation of extracellular signalregulated kinase (ERK), p38 mitogenactivated protein kinase and NF-kB/IkB signal transduction pathways thereby suppressing pro inflammatory cytokine production (Cho et al., 2003) .
These various mechanisms account for several clinical effects such as anti-atherosclerotic, antitumor, anti-thrombogenic, anti-osteoporotic and antiviral effects of quercetin observed in organisms (Nijveldt et al., 2001; Perez-vizcaino et al., 2006; Gong et al., 2009) . Besides the beneficial properties of quercetin, studies have shown its ability to induce toxic responses in in vivo and in vitro experiments. The earliest evaluations of quercetin for toxicity observed quercetin's ability to exhibit frameshift mutagenic activity in bacterial strains (Bjeldanes & Chang, 1977) , chromosomal aberration and sister chromatoid exchange in mammalian cells (Carver et al., 1983) . Several studies confirmed and extended the initial observations of Bjeldanes and Chang (1977) and thus established quercetin as one of the most mutagenic flavonoids. (MacGregor & Jurd, 1978; Brown & Dietrich, 1979; Rueff et al., 1986) . In vivo evaluation of quercetin showed its ability to act as a genotoxicant causing damage at the post meiotic stage of spermatogenesis in experimental rats. (Rastogi & Levin, 1987) . A two year study of quercetin in male and female rats also showed treatment related lesions in the kidney of male rats and the possibility of quercetin's toxic effects occurring with increase in age of the organism (Dunnick & Hailey, 1992) .
Toxicity testing of several elements, substances and compounds has aided the provision of relatively safe and hazard free conditions of existence for living organisms at various organizational levels. The mutagenicity and and genotoxicity testing of quercetin has been that of an ongoing investigative process. The mutagenic and genotoxic potential of quercetin has been extensively tested under in vitro and in vivo experimental conditions. Irrespective of metabolic activation, quercetin has displayed positive mutagenic activity when tested in vitro in most standard strains of Salmonella typhimirium (Bjeldanes & Chang, 1977; Hardigree & Epler, 1978; Brown & Dietrich, 1979; Ochiai et al., 1984; Hatcher & Bryan, 1985; Schimmer et al., 1988; Vrijsen et al., 1990) . The induction of SOS activity, reverse mutation and DNA single strand breaks in the presence or absence of metabolic activation has been observed in Escherichia coli (Hardigree & Epler, 1978; Llagostera et al., 1987; Rueff et al., 1986) . Similarly, mutagenic and genotoxic activities of quercetin has been confirmed in eukaryotic cells (Hardigree & Epler, 1978) and mammalian cells (Yoshida et al., 1980; Van der Hoeven et al., 1984; Rueff et al., 1986; Kubiak & Rudek, 1990; Gasper et al., 1994; Caria et al., 1995) . In these various studies, sister chromatid exchange, chromosomal aberrations, unscheduled DNA synthesis (UDS) and micronucleus formation were endpoints evaluated. However, a more recent evaluation of in vivo genotoxicity of quercetin with micronucleus formation and UDS as endpoints did not reveal signs of toxicity probably due to the extensive metabolism of quercetin in vivo (Utesch et al., 2008) .
Although quercetin has been observed to enhance the toxicity of most known chemical carcinogens Barotto et al., 1998; Matsukwa et al., 2002) , several more have shown its ability to exert protective effects over chemical carcinogens and several xenobiotic toxicity (Kang et al., 1999; De et al., 2000; Coskun et al., 2004; Coskun et al., 2005; Jin et al., 2006) . From these various documentations it could be deduced that establishing whether or not quercetin is toxic is an investigation far from over. In order to clearly establish the risk potential for humans, it is important to extensively examine the carcinogenicity or anti-carcinogenicity of quercetin.
Toxicity and the development of disease conditions depend to a certain extent on the expression or repression of a variety of genes in cells within an organism (Arreondo et al., 2005; Klaassen, 2008) . Genes are generally regarded as functional units of inheritance usually corresponding to the segment of deoxyribonucleic acid (DNA) coding for a single protein (Lodish, 2008) . Gene expression is a fundamental level at which genotype gives rise to phenotype in every organism (Sudbery, 2002) . The process of gene expression involves several steps including the transcription, RNA splicing, translation and post-translational modification of a protein (Orphanides & Reinberg, 2002) . The control of the amount and timing of appearance of the functional product of a gene known as gene regulation, allows every cell the capability of producing gene products as at when needed and gives it the flexibility to adapt to variable environment conditions, external signals and damage to the cell (Albert et al., 2010) . The importance of gene regulation and expression is shown in:
The control of insulin expression as a signal for blood glucose regulation (O' Brien & Granner, 1991; Goodison et al., 1992) .
The control of eukaryotic cell cycle progression through cyclin expression levels (Jiang et al., 1993) .
The inactivation of X chromosome in female mammals preventing an "overdose" of genes contained in chromosome (Avner & Heard, 2001; Csankovszki et al., 2001) .
Several gene expressions are regarded as important in the activities of organism at the cellular level. The expression of p21 is induced concomitantly with cellular senescence (Noda et al., 1994) with its over expression resulting in cell cycle arrest in either G1 and G2 or in S-phase (Ogryzko et al., 1997; Niculescu et al., 1998) . The initial discovery of p21 WAF1/CIP1 regarded it as a negative regulator of cell cycle progression (Roninson, 2002) . p21 WAF1/CIP1 directly regulates cyclin-dependent kinase (CDK) activity (Harper et al., 1993) , and mediates p53 induced growth arrest (el-Deiry et al., 1993) . The activity of p21 is strongly induced by DNA damage in cells expressing wild-type p53 (el-Deiry et al., 1994) . Interactions which bear on the function of p21 in cell cycle and/or DNA synthesis control result from direct binding with p21 and others a competitive mechanism for a common target (Dotto, 2000) . p21 controls E2F-dependent transcription through its effects on cyclin/CDK activity and substrate association which possibly results in specific repression of E2F-dependent transcription (Shiyanov et al., 1996) . cDNA microarray experiments reveal increased p21 expression as a cause of relatively specific suppression of cell cycle progression genes and induction of genes associated with senescence and age-related conditions like atherosclerosis and Alzheimer disease (Chang et al., 2000) . The increased expression of p21 WAF1/CIP1 has been correlated with enhanced death in cancer cell lines (Sheikh et al., 1995; Prabhu et al., 1996 , Li et al., 1997 Sheikh et al., 1997) . Quercetin inhibits DNA synthesis and induces apoptosis through increased c-fos mRNA levels, up-regulation of p21 mRNA and protein expression during liver regeneration following partial hepatectomy (Iwao & Tsuamoto, 1999) . Quercetin is shown to inhibit the expression of p21-RAS in human colon cancer cells (Ranelletti et al., 2000) and G1 cell cycle arrest independent of p27 and p53 in vascular smooth muscle cells (Moon et al., 2003) . Quercetin -induced increase in p21 WAF1/CIP1 levels in association with Cdc2-cyclin B1 complex induced growth inhibition in human breast carcinoma cell line MCF-7 (Choi et al., 2001 ).
The metabolism of several xenobiotics especially poly aromatic hydrocarbons (PAHs) is associated with the up-regulation of cytochrome p450 metabolizing enzyme CYP1A1 (Klaassen, 2008) . The cytochrome p450s (CYP p450) are a superfamily of microsomal drug metabolizing enzymes which catalyze various reactions (Gibson & Skett, 2001) . Various genes of this superfamily are induced by xenobiotics which bind to specific intracellular receptors and modulate their genetic expression (Klaassen, 2008) . CYP1A1 is a polymorphic isoform which binds and oxidizies planar aromatic, essentially flat molecules and appears to be more of a threat than a protection due to its elevated levels of expression in carcinogenesis (Coleman, 2005) . CYP1A1 is a phase 1 drug metabolizing enzyme with the major function of oxidizing hydrophobic PAHs as the first step to their elimination (Gibson & Skett, 2001 ). This explains its primary physiological function to be detoxification. However, CYP1A1 could lead to toxicity through mechanisms such as oxidative DNA damage and DNA adduct formation (Klaassen, 2008) . The presence of quercetin in St. John's wort has been show to exhibit a strong inhibitory potency on CYP1A1 activity induced by benzo[a]pyrene (B[a]P) (Schwarz et al., 2003) . Quercetin exhibited protective mechanism against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes treated with hydrogen peroxide (H 2 O 2 ) and B[a]P (Wilms et al., 2005) . Similarly, quercetin inhibited B[a]P-induced DNA adducts in human hepatoma cell lines (HepG2) by altering CYP1A1 gene expression (Kang et al., 1999) . Using various cell lines, several experimental studies have shown the ability of quercetin to exert protective and anti-carcinogenic effects. The effect of quercetin for this experiment was observed on proliferating breast carcinoma (MCF-7) cell lines in the presence and absence of the carcinogen benzo[a]pyrene.
MATERIALS AND METHODS
Chemicals. All chemicals, including test chemicals were obtained from Sigma Chemical Co. (Poole, UK) unless otherwise stated. Cell culture consumables were obtained from Invitrogen Life Technologies (UK) unless otherwise stated.
Cell culture:
The human mammary carcinoma cell line (MCF-7) (a gift from the institute of Cancer Research, UK) was grown in Dulbecco's modified essential medium (DMEM) supplemented with 10% heat-inactivated foetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin. MCF-7 cells were cultured routinely in 75cm 2 flasks at 5% CO 2 in air and 37oC in a humidified atmosphere and sub cultured (1:10 v/v) twice every week.
Clonogenic Assay: Prior to incorporation into experiments, cultured cells were disaggregated using 5 ml of a 0.05% trypsin solution for 5mins to form single cell suspension. Trypsin was inactivated using 5ml of complete DMEM and cells were centrifuged at 1000 rpm for 5 mins. Cell pellets were resuspended in 10 ml of complete DMEM and 5 ml aliquots containing 2.5 x 10 2 cells were seeded into 25 cm 2 flasks in the presence or absence of graded concentrations of quercetin and B[a]P using dimethyl sulfoxide (DMSO) as vehicle solvent and control.
The cells were incubated in 5% CO 2 in air at 37 o C in a humidified atmosphere for 24 h. The medium was then replaced with fresh DMEM without B[a]P or quercetin and cells were cultured undisturbed for a further 7days before the removal of medium and fixation with 70% ethanol. Colonies were then stained with 5% giemsa, counted and plating efficiencies calculated.
Cytokinesis Block Micronucleus (CBMN) Assay:
Cultured cells were disaggregated using 5 ml of a 0.05% trypsin solution for 5 mins to form single cell suspension. trypsin was inactivated using 5 ml of complete DMEM and cells centrifuged at 1000 rpm for 5 mins. Cell pellets were resuspended in 10 ml of DMEM. 3 ml aliquots (~2 x 10 4 cells) were seeded into 30 mm petri dishes containing 20 mm coverslips (Sarstedt, UK). Cells were incubated in 5% CO 2 in air at 37 o C in a humidified atmosphere for 24 h to enable the cell recovery from the effect of trypsin and cell attachment to coverslips. Cells were treated with graded concentrations of quercetin ± B[a]P for 24 h added as solutions in DMSO. After 24 h, the medium was replaced with fresh medium without quercetin or B[a]P but containing 6 µg/ml cytochalasin B. Cells were culture for a further 24 h prior to removal of medium and fixation with 70% ethanol. Cells were then stained with freshly prepared 5% Giemsa and coverslips washed in deionized water to remove excess giemsa. Coverslips were mounted in DPX mountant (BDH, UK), on microscope slides. For each treatment, micronuclei in 500 binucleate MCF-7 cells from a minimum of three experiments were scored. Mitotic rate was assessed as percent binucleate cells (Mean ± SD, n=3).
Quantitative Real-Time Reverse TranscriptasePolymrease Chain Reaction: Total RNA extraction was performed using the Qiagen RNeasy® kit in combination with Qiagen RNase-free DNase kit (Qiagen Ltd). RNA (0.8 µg) was reverse transcribed in a final volume of 40 µl following the Applied Biosystems Inc.(ABI) protocol using Taqman reverse transcription reagents kit (Applied Biosystems, Warrington, Cheshire UK). Final concentrations of reaction components used were 1x Taqman RT buffer; MgCl2 (5.5 mM); Oligo dTs (2.5 µM); dNTP mix 500 µM per dNTP; RNase inhibitor (0.4 U/µl); Multiscribe reverse transcriptase (1.25 U/µl) and RNase-free water.
cDNA samples were stored at -20 o C prior to use. Reaction mixtures contained 2x SYBR Green PCR master mix (Applied Biosystems, Warrington UK); forward and reverse primers (Invitrogen, Paisely UK) at a concentration of 5 µM; for CYP1A1, p21 amplification 20 ng or for β-Actin amplification 5 ng cDNA template; made to a total volume of 25 µl with sterile H 2 O. Each reaction was performed in triplicate and "no-template" controls were included in each experiment. Thermal cycling parameters included activation at 95 o C (10 min) followed by 60 cycles each of denaturation at 95 o C (15 s) and annealing/extending at 60 o C (1 min). Quantitative real-time PCR was performed using the ABI Prism 7000 Sequence Detection System (Applied Biosystems).
Statistical Analysis: Plaiting efficiency and percentage survival are expressed as the mean ± standard deviation (SD) from at least three independent experiments. In quercetin, mean differences of treated to control groups were analyzed by Students t-test (Unpaired two-tailed). Differences with P ≤ 0.05 were considered statistically significant between groups. In cells treated with Quercetin ± B[a]P treated groups, mean differences of Quercetin + B[a]P treated group to both control and B[a]P group were analyzed by Students t-test (Unpaired two-tailed). Differences with P ≤ 0.05 were considered statistically significant between groups.
RESULTS
The effects of quercetin in the presence and absence of B Tables 1 and 2 
DISCUSSION
Flavonoids consist of a vast array of biologically active compounds ubiquitously found in plants and many extensively evaluated for their effects in clinical therapeutics and chemotherapy. Flavonoids have been shown to exert various effects in various cell lines. These effects include anti-oxidative, anticarcinogenic, anti-inflammatory and have been extensively reviewed (Middleton Jr. et al., 2000; Nijveldt et al., 2001; Erlund, 2004) . These polyphenolic compounds are observed to more commonly occur as glucuronide and sulphate conjugates in the bloodstream with the gastrointestinal lumen, cells of the intestinal wall and the liver regarded as important sites of flavonoid metabolism (Erlund, 2004; Walle, 2004) . Following metabolism, flavonoids possess the ability to induce and activate the synthesis of the primary enzyme system involved in metabolism of various lipophilic xenobiotics (Middleton Jr. et al., 2000) . As a potent natural nutritional antioxidant, the antioxidative effects of quercetin have been demonstrated in several pure in vitro and cellular systems. Howbeit, quercetin has been reported to exhibit pro-oxidant properties including reduction of transition metal ions producing species involved in the Fenton reaction (Cao et al., 1997) . This activity is known to result in DNA damage (Yamashita & Kwanishi, 2000) . Other mechanisms include the decrease of glutathione content and glutathione S-transferase activity (Sahu & Gray, 1996) . More importantly, the generation of hydrogen peroxide as a result of quercetin autooxidation is demonstrated as the mechanism underlying its pro-oxidative action (Canada et al., 1990) .
Cytotoxicity:
The activity of quercetin in cell culture (Figure 1) showed a clear dose-dependent cytotoxic effect at 0.5 µM concentration and above. This observation was consistent with quercetin-induced cytotoxicity observed in carcinomic human type II alveolar basal epithelial cells (A549) (Robaszkiewicz et al., 2007) . Results were even more consistent with basal cytotoxicity observed in McCoy mouse fibroblast cells (Soares et al., 2006) . The oxidative activation of quercetin to the intermediate semiquinone which generates superoxide (Metodiewa et al., 1998 ) is a possible mechanism underlying its cytotoxicity in cells. From documented studies, quercetin possibly possesses a cancer-cell specific anti-proliferation effect (Robaszkiewicz et al., 2007) . The ability to upregulate p21 expression in cells is another possible mechanism of quercetin-induced cell death as increased levels of p21 have been correlated with apoptosis in cancer cell lines. (Sheikh et al., 1995; Prabhu et al., 1996; Li et al., 1997; Sheikh et al., 1997) . The polycyclic hydrocarbon B[a]P has been extensively studied for its DNA damaging and carcinogenic properties. The formation of the ultimate carcinogen, a diolepoxide of B[a]P follows three separate enzymatic reactions mediated especially by the activity of cytochrome p450 1A1 (Sims et al., 1974; Yang et al., 1976; Klaassen, 2008) . Results from this study show significant Quercetin has been shown to actively inhibit CYP1A1 activity and the diolepoxide formation (Schwarz et al., 2003 (Schwarz et al., , 2005 . Quercetin is documented to be readily absorbed in human subjects, reaching micromolar concentrations in the plasma and urine (Hollman et al., 1997; Conquer et al., 1998; Meng et al., 2004) . The slow elimination of quercetin from the blood (Hollman & Katan, 1999) , suggests that repeated intake of quercetin in individuals with increased risk of cancer as a result of CYP1A1 activity could lead to a build-up reaching concentrations in the range of the half maximal inhibitory concentration (IC 50 ) values observed for quercetin inhibition (Schwarz et al., 2005) . Furthermore, cell proliferation possibly occurred by the regulation of p21 WAF1/CIP1 and the cellular antioxidants superoxide dismutase and glutathione peroxidase. However, these mechanisms are not entirely understood.
Genotoxicity:
The induction of micronuclei in cell cultures or human lymphocytes is mostly used to detect both clastogens and agents which affect the regular distribution of chromosomes at mitosis (Fenech, 1993) . The genotoxicity of quercetin is documented to be enhanced by cytosolic enzymes (Brown & Dietrich, 1979) as a protective effect of degradation afforded by superoxide-dismutase (SOD) present in S9 (Ochiai et al., 1984) . Early studies noted based on cultured mammalian cells in test systems that the genotoxicity of quercetin is not increased in the presence of metabolic activation by S9 (van der Hoeven et al., 1984; Rueff et al., 1986) . Quercetin has been documented to induce micronuclei in human lymphocytes in the absence of metabolic activation (Popp & Shimmer, 1991) . Quercetin failed to induce micronuclei in mouse bone marrow erythrocytes, human lymphocytes and V79 cell lines in vivo. When tested in vitro in human lymphocytes, quercetin showed significant induction of micronuclei formation in the absence and presence of S9 (Caria et al., 1995) . A more recent evaluation of the potential in vivo genotoxicity of quercetin in polychromatic-erythrocytes (PCE) did not show quercetin-induced increase in the number of micronucleated PCE after 24 or 48 h of dose administration (Utesch et al., 2008) . The above observations indicate in vivo metabolism as an important mechanism in quercetin's non-genotoxic effect in in vivo studies.
The induction of micronuclei in cells by quercetin in the present study portrays it as mildly genotoxic. Quercetin was observed to induce close to 2-fold increase in the total number of micronuclei occurrence at 0.5, 1.0, 10 and 100 µM compared to control (Figure 4 ). This observation however was statistically insignificant. The manifestation of genotoxicity in quercetin treated cells is possibly due to the auto-oxidation of quercetin and/or the generation of reactive oxygen species (Metodiewa et al., 1998) . In comparison to individual concentrations of B[a]P, quercetin reduced the occurrence of micronucleated binucleate cells and induced marked reductions in both the total number and the distribution of micronuclei in the presence of B[a]P concentrations (Figure 4 ). This observation is indicative of quercetin's effect on the B[a]P metabolizing enzyme CYP1A1 and quercetin protection over xenobiotic toxicity in proliferating cells. A beneficial property which has been widely documented for quercetin (Kang et al., 1999; De et al., 2000; Coskun et al., 2004; Coskun et al., 2005; Jin et al., 2006) . Percent binucleate cells scored as a measure of cell proliferation showed reduction in proliferation for quercetin treated cells compared to control. However, cell proliferation was observed to increase in B[a]P treated cells possibly associated with the ability of carcinogens to evade the cellular defence mechanism of G1 arrest known as the stealth property (Dipple et al., 1999; Khan & Dipple, 2000; Jiao et al., 2007) .
Gene Regulation: Increased levels of p21 WAF1/CIP1 expression has been correlated with enhanced death in cancer cell lines (Sheikh et al., 1995; Prabhu et al., 1996 , Li et al., 1997 Sheikh et al., 1997) . Quercetin has been documented to induce apoptosis in human breast cancer cell lines through the induction and up regulation of p21 WAF1/CIP1 in association with Cdc2-cyclin B1 complex (Choi et al., 2001) . Quercetin induced G1 cell cycle arrest in vascular smooth muscle cells by down regulating cyclins and CDKs and up regulating the CDK inhibitor p21 (Moon et al., 2003) . Quercetin's presence in St. John's wort is documented to exhibit a strong inhibitory potency on the activity of CYP1A1 (Schwarz et al., 2003) . A similar effect of quercetin is had been observered in studies with human hepatoma cell lines (Kang et al., 1999) Quantitative RT-PCR studies for quercetin effects returned few average threshold cycle (C T ) values as undetermined possibly due to experimental errors. Levels of p21 expression as determined by RT-PCR using 0.1 µM B[a]P as a calibrator control (Table 1) revealed highly elevated expression levels for 1.0 µM B[a]P. This observation explains the cytotoxic effects of 1.0 µM B[a]P observed in cell culture (Figure 3) . In contrast, levels of expression were reduced in cells incubated with quercetin in the presence of B[a]P concentrations. This down-regulation gives an insight to mechanisms possibly employed by quercetin in the stimulation of cell proliferation observed in cell culture (Figure 2 and 3) . Results of CYP1A1 gene expression (Table 2 ) revealed rather overly expressed levels compared to the control. However, if the results are considered, quercetin reduced the expression of CYP1A1 in the presence of B[a]P. this effect could be attributed to the ability of quercetin to inhibit the activity of CYP1A1 (Schwarz et al., 2005) . Preferably regarded as inconclusive, this observation necessitates re-evaluation of quercetin effects on CYP1A1 expression given the observations in cell culture and CBMN assay.
CONCLUSIONS:
Data presented in this work provide evidence of quercetin cytotoxicity possibly through metabolic activation. This activity of quercetin in MCF-7 cells makes quercetin a potential agent in the targeted inhibition of proliferating cancer cells. However, it is worth recognizing that the cellular effects of quercetin are a bit complex and necessitate further investigation. Similarly, data provided evidence of quercetin's mild genotoxicity and quercetin-regulation of p21 WAF1/CIP1 . Further investigation into molecular mechanism of cell cycle regulation by quercetin, the effect of quercetin on key regulators of p21 WAF1/CIP1 and metabolic activation of quercetin is necessary to derive a mechanistic pathway of quercetin-induced cytotoxicity. A re-evaluation of quercetin effects on CYP1A1 and optimization of all parameters is equally necessary. Evaluating quercetin in comparison to other flavonoids and the use of in vivo models in the evaluation of quercetin would enhance the understanding of quercetin and its bioactive potentials.
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